FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2001523787> ?p ?o ?g. }

• W2001523787 endingPage "363" @default.
• W2001523787 startingPage "348" @default.
• W2001523787 abstract "An experimental study into calcium phosphate (CP) nucleation and growth on cholesterol and cholestanol surfaces from a supersaturated simulated body fluid (SBF) is presented with the overall aim of gaining some fundamental insights into the pathological calcifications associated with atherosclerosis. Soaking of pressed cholesterol disks at physiological temperature in SBF solutions was found to lead to CP nucleation and growth if the disks were surface roughened and if an SBF with concentrations of the calcium and hydrogen phosphate ions at 2.25x physiological concentrations was used. The CP phase deposited was shown via SEM micrographs to possess a florette type morphology akin to that observed in earlier reported studies. The use of recrystallised cholesterol and cholestanol microcrystals as substrates for soaking in SBF facilitated the observation of CP deposition. In general, cholesterol recrystallised from polar solvents like 95% ethanol as a cholesterol monohydrate phase which was a better substrate for CP growth than cholesterol recrystallised from more non-polar solvents (e.g., benzene) which produced anhydrous cholesterol phases. CP was also observed to form on recrystallised cholestanol microcrystals, a molecule closely related to cholesterol. Inductively coupled plasma optical emission spectrometry (ICP-OES) data gave confirmation that Ca:P mole ratios of the grown CP were 1.3-1.5 suggesting a mixed phase of octacalcium phosphate (OCP) and Ca-deficient HAp and that the CP coating grows (with time of soaking) on the substrates after nucleation in the SBF growth medium. Infrared (IR) spectra of the extracted coatings from the cholesterol substrates confirmed that the CP phase deposited is a semi crystalline HAp with either carbonate substituted into its structure or else co-deposited as calcium carbonate. Soaking experiments involving modified cholesterol substrates in which the OH group in the molecule was replaced with the oleiyl or phosphonate group showed no CP nucleation and growth. This observation illustrates the importance of the known epitaxial relationship between cholesterol and HAp (which theoretically predicts favourable deposition of one phase upon the other) and the consequences of its destruction (by chemical modification of the cholesterol). In the case of the phosphorylated cholesterol, failure of this substrate to nucleate CP phases may have also been caused by the reduction in concentration of free solution Ca2+ in the SBF medium by complexation with the phosphonate groups on the phosphorylated cholesterol. This would have reduced the ion product of Ca2+ and inorganic phosphate and lowered the degree of supersaturation in the SBF medium." @default.
• W2001523787 created "2016-06-24" @default.
• W2001523787 creator A5018475095 @default.
• W2001523787 creator A5069153878 @default.
• W2001523787 creator A5075394772 @default.
• W2001523787 date "2006-03-01" @default.
• W2001523787 modified "2023-10-18" @default.
• W2001523787 title "Growth of calcium hydroxyapatite (Ca-HAp) on cholesterol and cholestanol crystals from a simulated body fluid: A possible insight into the pathological calcifications associated with atherosclerosis" @default.
• W2001523787 cites W1755002895 @default.
• W2001523787 cites W1963695670 @default.
• W2001523787 cites W1965607994 @default.
• W2001523787 cites W1967402923 @default.
• W2001523787 cites W1975666154 @default.
• W2001523787 cites W1978708252 @default.
• W2001523787 cites W1983574597 @default.
• W2001523787 cites W1985374174 @default.
• W2001523787 cites W1995849206 @default.
• W2001523787 cites W1999521225 @default.
• W2001523787 cites W2013362190 @default.
• W2001523787 cites W2017151804 @default.
• W2001523787 cites W2032842297 @default.
• W2001523787 cites W2034624302 @default.
• W2001523787 cites W2036016028 @default.
• W2001523787 cites W2036313288 @default.
• W2001523787 cites W2040551968 @default.
• W2001523787 cites W2041163743 @default.
• W2001523787 cites W2046437408 @default.
• W2001523787 cites W2052363570 @default.
• W2001523787 cites W2054077528 @default.
• W2001523787 cites W2054117558 @default.
• W2001523787 cites W2055127656 @default.
• W2001523787 cites W2069573191 @default.
• W2001523787 cites W2070699680 @default.
• W2001523787 cites W2072527305 @default.
• W2001523787 cites W2090757077 @default.
• W2001523787 cites W2110999555 @default.
• W2001523787 cites W2116485994 @default.
• W2001523787 cites W2126512560 @default.
• W2001523787 cites W2185829196 @default.
• W2001523787 cites W2606276362 @default.
• W2001523787 cites W336553931 @default.
• W2001523787 doi "https://doi.org/10.1016/j.jcis.2005.09.013" @default.
• W2001523787 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16229855" @default.
• W2001523787 hasPublicationYear "2006" @default.
• W2001523787 type Work @default.
• W2001523787 sameAs 2001523787 @default.
• W2001523787 citedByCount "45" @default.
• W2001523787 countsByYear W20015237872012 @default.
• W2001523787 countsByYear W20015237872013 @default.
• W2001523787 countsByYear W20015237872014 @default.
• W2001523787 countsByYear W20015237872015 @default.
• W2001523787 countsByYear W20015237872016 @default.
• W2001523787 countsByYear W20015237872017 @default.
• W2001523787 countsByYear W20015237872018 @default.
• W2001523787 countsByYear W20015237872019 @default.
• W2001523787 countsByYear W20015237872020 @default.
• W2001523787 countsByYear W20015237872022 @default.
• W2001523787 crossrefType "journal-article" @default.
• W2001523787 hasAuthorship W2001523787A5018475095 @default.
• W2001523787 hasAuthorship W2001523787A5069153878 @default.
• W2001523787 hasAuthorship W2001523787A5075394772 @default.
• W2001523787 hasConcept C114874019 @default.
• W2001523787 hasConcept C178790620 @default.
• W2001523787 hasConcept C185592680 @default.
• W2001523787 hasConcept C199289684 @default.
• W2001523787 hasConcept C200447597 @default.
• W2001523787 hasConcept C2775971857 @default.
• W2001523787 hasConcept C2777746296 @default.
• W2001523787 hasConcept C2778163477 @default.
• W2001523787 hasConcept C2778718757 @default.
• W2001523787 hasConcept C2780022283 @default.
• W2001523787 hasConcept C2781471481 @default.
• W2001523787 hasConcept C2910061293 @default.
• W2001523787 hasConcept C519063684 @default.
• W2001523787 hasConcept C55493867 @default.
• W2001523787 hasConcept C61048295 @default.
• W2001523787 hasConceptScore W2001523787C114874019 @default.
• W2001523787 hasConceptScore W2001523787C178790620 @default.
• W2001523787 hasConceptScore W2001523787C185592680 @default.
• W2001523787 hasConceptScore W2001523787C199289684 @default.
• W2001523787 hasConceptScore W2001523787C200447597 @default.
• W2001523787 hasConceptScore W2001523787C2775971857 @default.
• W2001523787 hasConceptScore W2001523787C2777746296 @default.
• W2001523787 hasConceptScore W2001523787C2778163477 @default.
• W2001523787 hasConceptScore W2001523787C2778718757 @default.
• W2001523787 hasConceptScore W2001523787C2780022283 @default.
• W2001523787 hasConceptScore W2001523787C2781471481 @default.
• W2001523787 hasConceptScore W2001523787C2910061293 @default.
• W2001523787 hasConceptScore W2001523787C519063684 @default.
• W2001523787 hasConceptScore W2001523787C55493867 @default.
• W2001523787 hasConceptScore W2001523787C61048295 @default.
• W2001523787 hasIssue "2" @default.
• W2001523787 hasLocation W20015237871 @default.
• W2001523787 hasLocation W20015237872 @default.
• W2001523787 hasOpenAccess W2001523787 @default.
• W2001523787 hasPrimaryLocation W20015237871 @default.
• W2001523787 hasRelatedWork W1972007232 @default.
• W2001523787 hasRelatedWork W1976829511 @default.

• next